Many adults stop GLP-1 therapy within a year with low restart rates, analysis finds

A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults with overweight or obesity discontinued glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy within one year. Discontinuation rates were significantly higher and reinitiation rates were significantly lower for patients without type 2 diabetes.

Make America Healthy Again agenda at risk with reduction in force across federal health agencies

Staffing reductions across U.S. federal health agencies—including the Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), National Institutes of Health (NIH), and Agency for Health care Research and Quality (AHRQ)—pose a significant threat to public health, according to the Society for Health care Epidemiology of America (SHEA).

Visualization technique depicts brain-wide activity change as geometric patterns

Researchers at University of Tsukuba have applied a visualization technique to depict the brain’s activity related to visual perception as geometric patterns. They visualized different shapes, such as the ever-changing neuronal activity in the temporal and frontal lobes of the brain during object recognition and recalling memories. This achievement promises further extraction of brain activity observed in various aspects of daily life.